|
MSL3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.104380E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.717400E-01 |
| Normal-vs-Stage2 |
1.239210E-01 |
| Normal-vs-Stage3 |
3.234600E-01 |
| Normal-vs-Stage4 |
9.363000E-01 |
| Stage1-vs-Stage2 |
1.887390E-01 |
| Stage1-vs-Stage3 |
5.157000E-01 |
| Stage1-vs-Stage4 |
7.801400E-01 |
| Stage2-vs-Stage3 |
3.766200E-01 |
| Stage2-vs-Stage4 |
2.855400E-01 |
| Stage3-vs-Stage4 |
5.660000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.437200E-01 |
| Normal-vs-AfricanAmerican |
1.054450E-01 |
| Normal-vs-Asian |
3.771200E-01 |
| Caucasian-vs-AfricanAmerican |
3.118200E-01 |
| Caucasian-vs-Asian |
7.628000E-01 |
| AfricanAmerican-vs-Asian |
9.536000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.695800E-01 |
| Normal-vs-Female |
1.241090E-03 |
| Male-vs-Female |
7.563200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.587400E-01 |
| Normal-vs-Extreme_Weight |
9.360200E-01 |
| Normal-vs-Obese |
8.936100E-02 |
| Normal-vs-Extreme_Obese |
4.272400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.835200E-01 |
| Normal_Weight-vs-Obese |
3.817000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.951800E-01 |
| Extreme_Weight-vs-Obese |
7.951900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.180600E-01 |
| Obese-vs-Extreme_Obese |
4.506400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.543400E-03 |
| Normal-vs-Age(41-60Yrs) |
4.418900E-03 |
| Normal-vs-Age(61-80Yrs) |
8.962400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.159800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.107200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.529500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.121500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.324300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.423600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.812000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.113700E-02 |
| Normal-VS-Type2 PRCC |
5.288000E-01 |
| Normal-VS-KIRP CIMP |
9.630400E-02 |
| Normal-VS-Unclassified PRCC |
4.947800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.932080E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.937400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.834200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.826200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.416310E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.558000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.623400E-01 |
| Normal-vs-N1 |
2.841800E-02 |
| Normal-vs-N2 |
9.565200E-01 |
| N0-vs-N1 |
1.319970E-02 |
| N0-vs-N2 |
9.789200E-01 |
| N1-vs-N2 |
3.125000E-01 |
|
|
